Editorial: A good time to celebrate business success
OPINION: Sir Richard Taylor's inspiration was not lost on the Deloitte Top 200 crowd.
OPINION: Sir Richard Taylor's inspiration was not lost on the Deloitte Top 200 crowd.
OPINION: Risk and return are two important parts of investing.
Amazon Web Services (AWS) and Vector spin-out VTS extend their partnership.
After rocky ride, ERoad eyes up potential $10b US market.
Renewable energy subsidies abroad had tipped over several of software firm’s customers.
It was another topsy-turvy day for the NZ sharemarket.
Media Insider: Digital subscriptions now fund the NZ Herald newsroom.
OPINION: As inflation cools down, what are the signs of a likely boost to the NZX?
The latest reporting season was met with light trading.
Board sees "clear path" to doubled dividend by FY2026.
New Zealand stocks lose some of Monday's gains, driven by weaker banking stocks.
There will be plenty for shareholders to chew over.
A venture capital explainer. Plus: What National will and won’t do for start-ups and VCs.
The Israel-Hamas war has created volatility in gold and oil prices.
NZ households highly indebted by international standards.
OPINION: For genuine investors, the casino comparison couldn’t be further from the truth.
The tech giants to whom our retirement fortunes are tied.
New Zealand stocks remained boxed in by high interest rates and modest earnings growth.
The S&P/NZX 50 Index edged up 0.06 per cent.
The market didn't experience the jump that investors thought after the election result.
Relative underperformance of share price put down to usage of fossil fuels.
The company's pipe business has turned into a nightmare.
Most of the talk in the market was around Fletcher Building.
The transport company was now considering 'applicable emission targets for the group'.
The S&P/NZX 50 Index rose 13.1 points, or 0.12 per cent.
International funds coming in helped propel the local market.
It was a slow day for the market with light volumes traded.
No reason for optimism as we enter 'bear killer' month.
More light will be shed on the state of play with cash-strapped Synlait Milk on Monday.
Cheese and protein portfolios propel surge in Fonterra profit.